Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain antibodies, VHHs) to diagnostic or therapeutic nanoparticles, peptides, proteins, or drugs offers many opportunities for optimized targeted cancer treatment. Currently, mostly nonspecific conjugation strategies or genetic fusions are used that may compromise VHH functionality. In this paper we present a versatile modular approach for bioorthogonal VHH modification and conjugation. First, sortase A mediated transPEGylation is used for introduction of a chemical click moiety. The resulting clickable VHHs are then used for conjugation to other groups employing the Cu+-independent strain-promoted alkyne-azide cycloadition (SPAAC) reaction. Using t...
Antibody fusion to nonprotein materials such as contrast agents or radio-tracers, nano- or micropart...
Bispecific antibodies (BsAbs) for T cell engagement have shown great promise in cancer immunotherapy...
The antigen specificity and long serum half-life of monoclonal antibodies have made them a critical ...
Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain a...
Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain a...
Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain a...
Historically, bispecific antibodies have been constructed through the genetic fusion of additional b...
The therapeutic efficacy of antibodies can be successfully improved through targeted delivery of pot...
Expansion of antibody scaffold diversity has the potential to expand the neutralizing capacity of th...
The application of click chemistry, specifically Copper-Catalyzed Azide-Alkyne Cycloaddition (CuAAC)...
A unique two-step modular system for site-specific antibody modification and conjugation is reported...
Commercial antibody-drug conjugates (ADCs) are usually generated by unspecific conjugation of a toxi...
Bioconjugates are an indispensable tool for molecular biology as well as an established modality for...
The design of multifunctional polymer-based vectors, forming pDNA vaccines, offers great potential i...
The design of multifunctional polymer-based vectors, forming pDNA vaccines, offers great potential i...
Antibody fusion to nonprotein materials such as contrast agents or radio-tracers, nano- or micropart...
Bispecific antibodies (BsAbs) for T cell engagement have shown great promise in cancer immunotherapy...
The antigen specificity and long serum half-life of monoclonal antibodies have made them a critical ...
Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain a...
Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain a...
Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain a...
Historically, bispecific antibodies have been constructed through the genetic fusion of additional b...
The therapeutic efficacy of antibodies can be successfully improved through targeted delivery of pot...
Expansion of antibody scaffold diversity has the potential to expand the neutralizing capacity of th...
The application of click chemistry, specifically Copper-Catalyzed Azide-Alkyne Cycloaddition (CuAAC)...
A unique two-step modular system for site-specific antibody modification and conjugation is reported...
Commercial antibody-drug conjugates (ADCs) are usually generated by unspecific conjugation of a toxi...
Bioconjugates are an indispensable tool for molecular biology as well as an established modality for...
The design of multifunctional polymer-based vectors, forming pDNA vaccines, offers great potential i...
The design of multifunctional polymer-based vectors, forming pDNA vaccines, offers great potential i...
Antibody fusion to nonprotein materials such as contrast agents or radio-tracers, nano- or micropart...
Bispecific antibodies (BsAbs) for T cell engagement have shown great promise in cancer immunotherapy...
The antigen specificity and long serum half-life of monoclonal antibodies have made them a critical ...